跳至主要内容
临床试验/NCT06898424
NCT06898424已完成不适用

Effects of Concurrent Plant-Based Ketogenic Diet and Intermittent Fasting (Ketoflex 12/3) on the Clinical Progression of Early-to-Mid Stage Alzheimer's Dementia

Prof. Lutfu Hanoglu, MD1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年3月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Change in Cognitive Function as Measured by the MMSE Score

研究概览

简要总结

This study investigates the effects of the Ketoflex 12/3 diet on the clinical progression of early-to-mid stage Alzheimer's disease. The study evaluates cognitive function, metabolic changes, and overall health outcomes in participants following the Ketoflex 12/3 dietary protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 50-85 years
  • Clinical Dementia Rating (CDR) score of 1 or2
  • Diagnosis of Alzheimer's disease (AD) according to NIA-AA criteria

排除标准

  • Alcohol and/or substance dependence
  • Diagnosis of chronic renal failure
  • Diagnosis of another neuropsychiatric disorder
  • Presence of amalgam dental fillings and/or failure to have them removed following the SMART protocol

结局指标

主要结局

Change in Cognitive Function as Measured by the MMSE Score

时间窗: Baseline and 6 months

Mini-Mental State Examination (MMSE) will be used to assess cognitive function before and after the intervention. The Mini-Mental State Examination (MMSE) is used to assess cognitive function. The total score ranges from 0 to 30, with higher scores indicating better cognitive performance.

次要结局

未报告次要终点

研究者

发起方
Prof. Lutfu Hanoglu, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Prof. Lutfu Hanoglu, MD

Prof. MD

Istanbul Medipol University Hospital

研究点 (1)

Loading locations...

相似试验